Skip to main content
. 2013 Jan 22;7:193–198. doi: 10.2147/OPTH.S37938

Figure 1.

Figure 1

Tumor burden with brachytherapy alone (Abramson et al25) compared with combined treatment with plaque brachytherapy and intravitreal bevacizumab.